Tradestie Institutional Equity Comparison Engine

MPLT vs FDMT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MPLT Overall Edge

MPLT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MapLight Therapeutics, Inc. (MPLT) driven by superior Growth & Margin, Options & Structure while FDMT counters with relative strength in Momentum & Technical. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FDMT at N/M Forward P/E and -222.7% operating margin (+4505.6% YoY). In options structure, MPLT sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against FDMT sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MPLT N/M vs FDMT N/M Fwd P/E
Growth & Margin Winner MPLT
Op Margin 0.0% vs -222.7% ยท YoY +0.0% vs +4505.6%
Momentum & Technical Winner FDMT
1Y -51.4% vs +13.3% ยท 52W Pos 3% vs 47%
Options & Structure Winner MPLT
BREAKDOWN (8th %ile IV) vs BREAKDOWN (10th %ile IV)
MPLT US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$6.94
-4.28% 1D
Market Cap $392.9M
1M Return -9.87%
1Y Return -51.4%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 49.0 Fund 56.0 Flow 64.0 Mom 58.9
FDMT NASDAQ
4D Molecular Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$11.65
-4.74% 1D
Market Cap $669.3M
1M Return -4.04%
1Y Return +13.33%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 21.0 Fund 54.0 Flow 66.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MPLT -51.4% FDMT +13.33% Spread: +64.73 pp (FDMT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MPLT TTM Op. Margin: 0.0% FDMT TTM Op. Margin: -222.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPLT vs FDMT. Trailing 12-month operating profitability (MPLT 0.0% vs FDMT -222.7%) and valuation multiples (MPLT N/M vs FDMT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MPLT (4) vs FDMT (4)
Institutional Metric MPLT FDMT Criterion Row Winner
Market Capitalization Scale $392.9M $669.3M Larger Scale FDMT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +4505.6% Higher Growth FDMT
Operating Margin (TTM) Profitability 0.0% -222.7% Higher Margin MPLT
Net Profit Margin Profitability 0.0% -208.6% Higher Margin MPLT
Return on Equity (ROE) Capital Efficiency -111.5% -56.7% Higher ROE FDMT
52-Week Range Position Momentum 3% ($6โ€“$40) 47% ($7โ€“$17) Stronger Trend FDMT
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 78% Vol 1.89ฮฒ ยท 90% Vol Lower Realized Risk MPLT
Unified Institutional Score Composite Signal 50.4 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite MPLT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MPLT vs FDMT Buy Guide
MPLT BREAKDOWN
144d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live MPLT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FDMT BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live FDMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MPLT nor FDMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.